GCC Catheter Market Report by Product Type, End Users, Countries and Companies Analysis 2026-2034

GCC Catheter Market Size & Forecast 2026-2034

GCC Catheter Market is projected to grow from US$ 633.23 Million in 2025 to US$ 1,399.34 Million by 2034, driven by the increasing prevalence of cardiovascular diseases, urinary disorders, and chronic health conditions across the region. Rising healthcare expenditure, expanding hospital infrastructure, and growing adoption of minimally invasive procedures are further supporting market growth. The market is expected to register a Compound Annual Growth Rate (CAGR) of 9.21% during the forecast period from 2026 to 2034, reflecting strong demand for advanced catheter technologies and improved patient care solutions.

GCC Catheter Market Outlooks

A catheter is a thin, flexible medical tube that is inserted into the body to deliver fluids, drain bodily fluids, administer medications, or provide access for diagnostic and therapeutic procedures. Catheters are widely used in various medical specialties, including cardiology, urology, neurology, and critical care. Common types include urinary catheters, cardiovascular catheters, intravenous catheters, and specialty catheters designed for minimally invasive procedures.

In the GCC region, the popularity and demand for catheters have increased significantly due to the growing prevalence of chronic diseases such as cardiovascular disorders, diabetes, kidney diseases, and urinary tract conditions. The rising aging population, expanding healthcare infrastructure, and increasing adoption of advanced medical technologies are further supporting market growth. Governments across GCC countries are investing heavily in healthcare modernization and specialized treatment facilities, leading to greater utilization of catheter-based procedures. Additionally, the growing preference for minimally invasive surgeries, which offer faster recovery times and reduced hospital stays, has accelerated catheter adoption. Continuous technological advancements and improving healthcare accessibility are expected to further drive demand for catheter products across the GCC region.

GCC Diabetes Burden: 2024 vs 2050 Projection (Adults 20-79 years) in Million

Country 2024 2050 Growth Trend

Saudi Arabia 4.3 6.8-7.2 Strong increase

UAE 1 1.6-1.8 Moderate-high increase

Kuwait 0.65 0.95-1.05 Steady increase

Qatar 0.32 0.45-0.55 Moderate increase

Oman 0.4 0.70-0.85 High proportional growth

Bahrain 0.18 0.25-0.30 Moderate increase

Source: International Diabetes Federation (IDF) Diabetes Atlas (11th Edition, 2025), Lancet Diabetes & Endocrinology (IDF Atlas 2024-2050 projections study, 2026)

GCC Catheters Market News and Key Development:

• February 2024, Zylox-Tonbridge (2190.HK) has successfully received marketing approval from the Ministry of Health and Prevention in the United Arab Emirates for a suite of its cutting-edge products. This approval encompasses the ZENFluxiona"¢ Drug-coated PTA Balloon Catheter, ZENFlowa"¢ HP PTA Balloon Catheter, ZENFlowa"¢ PTA Balloon Catheter, ZENFlexa"¢ Peripheral Stent System, and ZENFLEX Proa"¢ Peripheral Drug-eluting Stent System.
• May 2025, Abbott, a global healthcare company, has announced the launch of the TactiFlex Sensor Enabled Ablation Catheter, the world's first ablation catheter featuring a flexible tip combined with contact force technology.
• In February 2025, Johnson & Johnson MedTech introduced the CEREGLIDE 92 catheter system, a next generation large bore catheter intended for acute ischemic stroke interventions, complementing existing neurovascular portfolios used globally, including in the GCC.
• In September 2025, Terumo Neuro announced the EMEA commercial availability of the SOFIA(TM) Flow 88 Neurovascular Aspiration Catheter, expanding access to a large-bore catheter used for stroke and neurovascular interventions. Although the announcement covers Europe, Middle East & Africa (EMEA) as a whole, this rollout includes GCC countries within the EMEA market where distributors supply the device to regional hospitals. The SOFIA Flow 88 catheter features optimized trackability and aspiration support to assist neurointerventional procedures. This marked one of the notable launches of advanced neurovascular catheter technology accessible in the GCC.

Growth Driver

Increased Burden of Chronic Diseases and Aging Population

The growing prevalence of chronic illnesses such as cardiovascular disorders, diabetes, and kidney-related diseases across the GCC region is significantly propelling demand for catheter-based medical solutions. At the same time, the region's expanding elderly population is contributing to higher healthcare needs, as older individuals are more susceptible to conditions that require diagnostic and therapeutic catheterization. Consistent with global trends highlighted by the World Health Organization, non-communicable diseases are rising steadily, and GCC countries are experiencing a similar pattern of disease burden. Cardiovascular conditions, in particular, account for a substantial share of mortality in the Middle East, estimated at around one-third of total deaths. This epidemiological shift is increasing the frequency of interventional procedures, many of which rely on different types of catheters, thereby strengthening the overall growth trajectory of the GCC catheter market.

Healthcare Infrastructure Expansion

The GCC region is witnessing rapid expansion and modernization of its healthcare infrastructure, driven by large-scale government initiatives aimed at delivering high-quality medical services. Strategic programs such as Saudi Arabia's Vision 2030 and comprehensive healthcare reforms in the UAE are accelerating the construction of advanced hospitals, specialty clinics, and integrated healthcare facilities equipped with modern medical technologies. This infrastructure development directly supports greater adoption of catheter-based diagnostic and treatment procedures, as newly established hospitals typically incorporate advanced interventional tools and minimally invasive systems as standard practice. The increasing presence of private healthcare providers and digital health investments is further enhancing service delivery capacity and patient access. For example, significant funding in digital health ecosystems, such as AI-enabled healthcare platforms, is helping build more connected and efficient care networks. Collectively, these developments are expanding procedural volumes and strengthening the demand for catheters across the GCC healthcare landscape.

Technological Developments and Minimally Invasive Procedures

Technological innovation and the growing preference for minimally invasive procedures are major factors driving catheter market growth in the GCC. Continuous advancements in catheter design have improved flexibility, precision, safety, and patient comfort, while also reducing procedure-related complications such as infections and long recovery times. These improvements align with healthcare systems in the region that aim to enhance efficiency and patient outcomes through modern medical technologies. As hospitals increasingly shift toward minimally invasive techniques, catheters have become essential tools in a wide range of diagnostic and therapeutic applications. Regulatory approvals for advanced devices, including drug-eluting stents, balloon catheters, and peripheral vascular systems, further reflect the region's openness to innovation. The adoption of such cutting-edge products enables healthcare providers to perform complex interventions with greater accuracy and reduced hospital stays. This ongoing technological evolution continues to expand clinical applications, thereby significantly boosting the GCC catheter market.

Challenge

High Cost of Advanced Catheterization Procedures

Despite strong growth prospects, the GCC catheter market faces challenges due to the high cost associated with advanced catheterization technologies and procedures. Sophisticated catheter systems and related interventional equipment often require substantial investment, making them less accessible for smaller or budget-constrained healthcare facilities. While large hospitals in urban centers may adopt these technologies, cost barriers can limit their widespread availability across all healthcare settings in the region. Additionally, the expenses involved in procurement, maintenance, training, and procedural execution further increase the overall financial burden on healthcare providers. This can result in unequal access to advanced catheter-based treatments among different patient groups. In some cases, healthcare systems may prioritize essential services over expensive technological upgrades, which can slow down adoption rates. Consequently, the high cost factor remains a significant restraint, potentially limiting market penetration and moderating the pace of growth in certain segments of the GCC catheter industry.

Regulatory Hurdles and Compliance Issues

The GCC catheter market is also constrained by complex regulatory frameworks that vary across individual countries in the region. Each nation has its own medical device approval processes, compliance standards, and documentation requirements, which can create delays in product registration and market entry. Manufacturers often face lengthy and resource-intensive approval procedures, increasing both time-to-market and operational costs. In addition, ensuring continuous compliance with evolving local regulations requires significant administrative effort and regulatory expertise. These challenges can slow down the introduction of innovative catheter technologies and limit their availability in certain healthcare systems. Differences in regulatory harmonization across GCC countries further complicate regional market expansion strategies for global and local manufacturers. As a result, companies may need to navigate multiple approval pathways, which can hinder rapid commercialization. Overall, regulatory complexity remains a key barrier, affecting the speed of product launches and restricting the seamless adoption of advanced catheter solutions in the GCC healthcare market.

GCC Cardiovascular Catheter Market

The cardiovascular catheter segment in the GCC region is experiencing strong expansion due to the rising prevalence of heart-related disorders and the growing reliance on interventional cardiology procedures. Increasing cases of coronary artery disease and other cardiac conditions have significantly boosted the demand for advanced catheter-based treatments. Continuous innovations in catheter technology, including drug-eluting stents, bioresorbable scaffolds, and improved guide catheters, are enhancing procedural success rates and patient recovery outcomes. Healthcare providers across the GCC are increasingly shifting toward minimally invasive cardiac interventions, which reduce hospital stay duration and post-operative complications. This transition is further supported by improved healthcare infrastructure and the availability of specialized cardiac care centers. As awareness of early diagnosis and treatment of cardiovascular diseases grows, the adoption of interventional procedures is expected to rise steadily, positioning cardiovascular catheters as a critical and rapidly expanding segment within the broader GCC medical device market.

GCC Microcatheters Market

The microcatheters segment in the GCC is gaining significant traction due to their essential role in highly precise neurovascular and peripheral vascular procedures. These devices are designed with exceptional flexibility and navigability, allowing physicians to access complex and narrow blood vessels with high accuracy. The increasing incidence of conditions such as cerebral aneurysms, stroke-related complications, and peripheral artery disease in the GCC is driving the demand for advanced microcatheter-based interventions. Their ability to deliver contrast agents, drugs, or devices deep within the vascular system makes them indispensable in modern minimally invasive surgeries. Growing adoption of interventional radiology and neurointervention techniques is further strengthening market growth. In addition, improvements in imaging technologies and catheter materials have enhanced procedural safety and efficiency. As healthcare systems in the GCC continue to adopt advanced surgical techniques, the demand for microcatheters is expected to grow steadily across hospitals and specialized treatment centers.

GCC Intermittent Catheters Market

The intermittent catheters market in the GCC is witnessing rising adoption due to their ease of use, improved patient comfort, and lower risk of infection compared to long-term indwelling catheters. These devices are primarily used for patients suffering from urinary retention, spinal cord injuries, and neurogenic bladder disorders. The increasing emphasis on home-based healthcare and self-catheterization practices is significantly contributing to market growth. Patients and healthcare providers are increasingly preferring intermittent catheters as they reduce the risk of urinary tract infections and allow better lifestyle flexibility. In addition, growing awareness regarding hygiene standards and advancements in catheter materials, such as hydrophilic coatings, are improving patient compliance and safety. The expansion of rehabilitation centers and long-term care facilities in the GCC is also supporting demand. Overall, the shift toward patient-centric care models and minimally invasive urinary management solutions is driving steady growth in the intermittent catheters segment across the region.

GCC Short PIVC Catheter Market

The short Peripheral Intravenous Catheter (PIVC) market in the GCC is expanding steadily due to its widespread use in hospitals, emergency departments, and outpatient care settings. These catheters are commonly used for administering medications, fluids, and blood products, offering a simple and efficient method for vascular access. Their ease of insertion, cost-effectiveness, and relatively low complication rates make them one of the most frequently used medical devices in clinical practice. The increasing number of hospital admissions, emergency cases, and outpatient surgical procedures in the GCC is driving consistent demand for short PIVCs. Additionally, improvements in catheter design, such as enhanced biocompatibility and anti-infection features, are further improving safety and performance. Healthcare providers are also focusing on reducing catheter-related complications, which is encouraging the adoption of advanced PIVC products. As healthcare delivery continues to expand across the region, the short PIVC segment is expected to maintain strong growth momentum.

GCC Catheter Hospitals Market

Hospitals in the GCC represent a major end-user segment for catheters due to the high volume of diagnostic, therapeutic, and surgical procedures performed in these facilities. Catheters are widely utilized across multiple departments, including cardiology, urology, emergency medicine, and intensive care units. The centralization of advanced healthcare services in hospitals ensures continuous and large-scale demand for various catheter types. Ongoing investments in hospital infrastructure, along with the adoption of advanced medical technologies, are further strengthening catheter utilization rates. The expansion of multispecialty hospitals and tertiary care centers in the region has also increased the frequency of complex interventional procedures requiring catheterization. Additionally, government initiatives aimed at improving healthcare quality and accessibility are supporting hospital growth and modernization. As hospitals continue to integrate minimally invasive techniques into routine practice, the reliance on catheter-based procedures is expected to rise steadily, reinforcing the hospital segment as a key driver of the GCC catheter market.

Saudi Arabia Catheter Market

Saudi Arabia represents the largest share of the GCC catheter market, driven by its substantial population base and continuous government-led investments in healthcare development. The country's Vision 2030 initiative is a key growth enabler, focusing on expanding healthcare capacity, modernizing medical infrastructure, and increasing access to advanced treatment technologies, including catheter-based procedures. Rising cases of chronic diseases such as cardiovascular disorders, diabetes, and renal conditions are further intensifying the demand for diagnostic and interventional catheterization. The Kingdom is actively working toward building a large network of healthcare facilities, including hospitals, clinics, and specialty centers, which is significantly boosting the consumption of medical devices. Large-scale funding allocations for healthcare infrastructure development are supporting procurement of advanced surgical and diagnostic tools. As hospitals become more technologically advanced and patient volumes continue to grow, the adoption of catheters across multiple specialties is expected to rise steadily in Saudi Arabia.

UAE Catheter Market

The catheter market in the United Arab Emirates is expanding rapidly, supported by a highly developed healthcare system and strong emphasis on medical tourism. The country continues to invest heavily in cutting-edge healthcare infrastructure and digital health technologies, enabling widespread adoption of advanced catheterization techniques. Increasing patient preference for minimally invasive procedures is further accelerating demand for innovative catheter-based solutions. The UAE's position as a regional healthcare hub attracts international patients, encouraging hospitals to maintain high standards of medical technology and procedural efficiency. Ongoing advancements in interventional radiology and vascular procedures are also contributing to market growth. In addition, recent clinical achievements, such as successful embolization procedures using advanced microcatheter systems, highlight the growing use of specialized catheter technologies in complex treatments. These developments reflect the UAE's strong focus on innovation and quality healthcare delivery, positioning it as one of the fastest-growing catheter markets within the GCC region.

Kuwait Catheter Market

The catheter market in Kuwait is experiencing steady growth, driven by the increasing prevalence of lifestyle-related diseases and ongoing improvements in the national healthcare system. Rising cases of obesity, diabetes, and cardiovascular conditions are contributing to greater demand for catheter-based diagnostic and therapeutic procedures. The government's commitment to strengthening healthcare infrastructure through hospital expansion and modernization is also supporting market development. Investments in advanced medical technologies and the introduction of new treatment devices are enhancing clinical capabilities across healthcare facilities. There is also a growing focus on improving patient care quality and ensuring access to modern medical interventions, which is positively influencing catheter adoption. Additionally, the introduction of innovative products in the broader EMEA region, such as haemostatic sealing patches and advanced aspiration catheters, reflects the region's increasing access to next-generation medical technologies. Overall, these factors are collectively driving the steady expansion of the catheter market in Kuwait.

GCC Catheter Market Segmentation

Product Type

• Cardiovascular Catheters
• Cardiovascular Therapeutic Catheters
• Cardiovascular Diagnostic Catheters

Neurovascular Catheters

• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Urinary Catheters

• Intermittent Catheters
• Foley/Indwelling Catheters
• External Catheters

Intravascular Catheters

• Short PIVC
• Integrated/Closed PIVC

Specialty Catheters

End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Others

Countries

• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman
• Bahrain
• Rest of GCC

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Abbott Laboratories
• Edwards Lifesciences Corp
• Becton Dickinson And Company
• Boston Scientific Corporation
• Medtronic Plc.
• Johnson & Johnson
• Stryker Corporation
• Teleflex Inc.